Skip to main content
. 2020 Dec 31;21(2):159. doi: 10.3892/ol.2020.12420

Figure 1.

Figure 1.

Effect of TFAP2B expression in patients with PAAD in TCGA cohort. (A) B3GNT3 expression in pancreatic cancer (47.45±29.06) and normal pancreas (7.36±7.44) samples. Effect of B3GNT3 expression on (B) disease-free survival and (C) overall survival in patients with pancreatic adenocarcinoma in the cohort from TCGA (n=171; overall survival HR=2.1, P=0.00076; disease-free survival HR=1.6, P=0.029). **P<0.01. B3GNT3, βGal β-1,3-N-acetylglucosaminyltransferase 3; HR, hazard ratio; TPM, transcripts per million.